Consequences of bile duct obstruction on intestinal expression and function of multidrug resistance-associated protein 2☆

This publication has 35 references indexed in Scilit:

• Role of MRP2 and GSH in intrahepatic cycling of toxins
  Toxicology, 2001
• Increased Bioavailability of the Food-Derived Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in MRP2-Deficient Rats
  Molecular Pharmacology, 2001
• Mrp2-deficiency in the rat impairs biliary and intestinal excretion and influences metabolism and disposition of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)
  Carcinogenesis, 2001
• Molecular Alterations in Hepatocyte Transport Mechanisms in Acquired Cholestatic Liver Disorders
  Seminars in Liver Disease, 2000
• Transport of Topoisomerase I Inhibitors by the Breast Cancer Resistance Protein: Potential Clinical Implications
  Annals of the New York Academy of Sciences, 2000
• The Effect of Rifampin Treatment on Intestinal Expression of Human MRP Transporters
  The American Journal of Pathology, 2000
• Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export
  British Journal of Cancer, 2000
• A multidrug resistance transporter from human MCF-7 breast cancer cells
  Proceedings of the National Academy of Sciences, 1998
• Glutathione-related mechanisms in cellular resistance to anticancer drugs.
  International Journal of Oncology, 1998
• The canalicular multispecific organic anion transporter and conjugated hyperbilirubinemia in rat and man
  Journal of Molecular Medicine, 1997